45 results
424B5
ENLV
Enlivex Therapeutics Ltd
30 Dec 22
Prospectus supplement for primary offering
4:01pm
that the duration of the transaction is reasonable given the circumstances related thereto.
Arrangements regarding the terms of engagement
6-K
EX-99.1
ENLV
Enlivex Therapeutics Ltd
5 Oct 22
Notice of Annual General Meeting of Shareholders
3:00pm
, such that 25% of the options shall vest on each of the four anniversaries of the date of grant, subject to Mr. Novik’s continued engagement … of the three anniversaries of the date of grant, subject to Mr. Novik’s continued engagement by the Company on each applicable vesting date.
In each case
F-3
ENLV
Enlivex Therapeutics Ltd
29 Apr 22
Shelf registration (foreign)
8:14am
regarding the terms of engagement and compensation of a controlling shareholder who is an office holder, and the terms of employment of a controlling
6-K
EX-99.1
o3h1p
30 Sep 21
Annual and Extraordinary General Meeting of Shareholders
8:01am
6-K
EX-1.1
cwrjrkloqz4
12 Feb 21
Enlivex Announces Closing of Previously Announced Bought Deal Offering of Approximately $46.0 Million Ordinary Shares
5:17pm
6-K
EX-10.1
75npu8cna 06nz30
12 Feb 21
Enlivex Announces Closing of Previously Announced Bought Deal Offering of Approximately $46.0 Million Ordinary Shares
5:17pm
424B5
zpq pyjwqwtqhk
10 Feb 21
Prospectus supplement for primary offering
5:22pm
424B5
eu0ieamex8gj ttdc
9 Feb 21
Prospectus supplement for primary offering
4:56pm
6-K
EX-10.1
3mcduz90wic8vnab3r
22 Oct 20
Report of Foreign Private Issuer
8:47am
424B5
du663srm9grl2t76kaj
22 Oct 20
Prospectus supplement for primary offering
8:45am
6-K
EX-99.1
4cfvr09b crt
19 May 20
Annual and Extraordinary General Meeting of Shareholders
8:04am
6-K
EX-4.2
sprbhz
5 Mar 20
Report of Foreign Private Issuer
8:16am
6-K
EX-5.2
k6320sd
5 Mar 20
Report of Foreign Private Issuer
8:16am
424B5
x56eiuixpcqr22
3 Mar 20
Prospectus supplement for primary offering
5:13pm
6-K
EX-5.2
e1a bbdh3
26 Feb 20
Enlivex Therapeutics Closes $8.0 Million Registered Direct Offering
4:15pm